Skip to main content
Clinical Trials/NCT05971615
NCT05971615CompletedNot Applicable

Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen

University Hospital, Caen1 site in 1 country90 target enrollmentStarted: January 15, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
90
Locations
1
Primary Endpoint
lactates on peripheral venous and arterial blood gases

Study Overview

Brief Summary

concordance between the lactate values on peripheral venous and arterial blood gases in all patients receiving an arterial sample on their arrival in the S.A.U.V.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • one of this condition in emergency unit :
  • acute respiratory distress
  • a suspicion of an acid-base disorder
  • a state of shock
  • Pathologies requiring monitoring of the respiratory system
  • Patient under NIV
  • Coma with a Glasgow score < or equal to 8

Exclusion Criteria

  • Patient presenting another pathology supported in SAUV not requiring the realization of arterial blood gases
  • Patient aged < 18 years
  • Pregnant or breastfeeding woman

Outcomes

Primary Outcomes

lactates on peripheral venous and arterial blood gases

Time Frame: baseline

mmol/L

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials